Regeneron Pharmaceuticals Inc at Truist BioPharma Symposium Transcript
Good morning, everyone. What a delight to have Dr. Len Schleifer here today. I think I've known Len since I was a baby analyst. A really bad one, but much better now. And with them, we also have Ryan Crowe from Investor Relations as well. So thank you so much. Before we begin, both of us have to disclosures. So here are mine, because this is being webcast. So don't scream anything out, it's going to be transcribed and live. This call is arranged by Truist Securities Research for institutional investors and issuer clients only as defined by FINRA. If you're not an individual investor or issuer, please disconnect this time. For required disclosures, please see our website at truistsecurities.com or equity research library. So with that, I'll turn it over to you.
Now it's my turn. Thank you, Robyn, for hosting us here at Truist. Great to be here. I'd like to remind you that our remarks made today may include forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |